Sanofi receives SEC recommendation to bring new therapies of Pompe, ASMD to India EP News Bureau Feb 28, 2023 The company hopes to launch these therapies in India by end of 2023 or beginning of next year, subject to completion of all…
US FDA approves Nexviazyme for late-onset Pompe disease EP News Bureau Aug 9, 2021 The approval is based on the positive phase-III data demonstrating improvements in key disease burden measures and establishing…
